The biotechnology giant Regeneron has substituted for Intel as the Science Talent Search host. It seems to be a case of the baton having been passed on to another entity.
Regeneron, a biotechnology company, has been given the go-ahead signal to sponsor the most elevated US science talent show for high school students. The microchip maker Intel was left in the background and it has been replaced by Regeneron.
Don't Miss: iPhone 8: Everything You Need to Know
Regeneron generously gave $100 million in order to host the Science Talent Search as well as other similar programs that will be held between now and 2026.
The award money for the winners of the Science Talent Search was doubled to $2000 per participant. Two of the top brass executives of Regeneron had competed in the event way back in the 70s.
They then took the initiative and built the biggest pharmaceutical company that was busy searching for cures to macular degeneration, cancer and high cholesterol levels in individuals.
The drugs churned out by Regeneron were cutting-edge. Intel had become the sponsor for the Science Talent Search in the late 90s. Yet now the designation has been passed onto Regeneron, WSJ reported.
Before Intel, Westinghouse had been the official sponsor of the prestigious competitive show. Its heyday remained extant from 1942 to 1997. This healthy competition is comandeered by a nonprofit agency.
The number of requests for participation come from 1800 high school seniors who are adept in their fields of endeavor. The subjects span the sciences and include the King of Sciences, Mathematics.
Ultimately after much shortlisting, 300 young scientists are left behind. From these 40 are further chosen as special cases that will participate in the competition. The arena where they face off against one another is Washington D.C.
The Chief Executive of Regeneron participated in the Science Talent Search in 1970. His project was on Euclidian Geometry. As for the Research Chief of Regeneron, he participated in 1976 and his project involved cutting protozoa to see how they regenerated their primitive biological structures.
These two talented individuals stuck to the theme that had brought them fame and recognition when they laid the foundation of Regeneron. They hoped to find a cure for Parkinson’s and Alzheimer’s.
While this was not achieved, the company showed a high growth rate and new avenues of research were pursued by these executives. Today Regeneron is at the forefront of leading edge research and it is a name to be reckoned with.